期刊
HEART RHYTHM
卷 9, 期 10, 页码 1718-1726出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.hrthm.2012.05.016
关键词
Short-term variability; Torsades de pointes; Chronic AV block dog; Drugs; Long QT syndrome; Repolarization; Biomarkers
资金
- European Community's Seventh Framework Programme [HEALTH-F2-2009-241526]
Pharmacological safety evaluation of (pro) drugs includes cardiac safety assessment of proarrhythmic liability in healthy tissue with emphasis on the rapid component of the delayed rectifier (I-Kr). The lack of (1) an arrhythmic end point, (2) tests in remodeled, predisposed tissue, and (3) testing chronic drug influence on channel trafficking impairs on the drawn conclusions of these assays regarding drug safety. Moreover, the currently used human ether-a-go-go-related gene assays, action potential duration, prolongation in multicellular preparations, or the QT interval have significant shortcomings in their prediction of an increased risk for drug-induced torsades de pointes arrhythmia. In this review, it will be proposed that beat-to-beat variability of repolarization quantified as short-term variability can (1) discriminate between safe and unsafe drugs even under predisposed and highly arrhythmogenic conditions despite accompanying QT prolongation and (2) identify the individual at risk for subsequent arrhythmic events.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据